Andrewes FW, Horder TJ, A STUDY OF, THE STREPTOCOCCI PATHOGENIC FOR MAN. The Lancet. 1906;168(4335):852–5.

Article  Google Scholar 

Crank C, O’Driscoll T. Vancomycin-resistant enterococcal Infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;217.

Pfaller MA, Cormican M, Flamm RK, Mendes RE, Jones RN. Temporal and Geographic Variation in Antimicrobial susceptibility and resistance patterns of Enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–2016. Open Forum Infect Dis. 2019;6(Supplement1):54–62.

Article  Google Scholar 

Faron ML, Ledeboer NA, Buchan BW. Resistance mechanisms, Epidemiology, and approaches to Screening for Vancomycin-resistant Enterococcus in the Health Care setting. J Clin Microbiol. 2016;54(10):2436–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Courvalin P. Vancomycin Resistance in Gram-positive Cocci. Clin Infect Dis. 2006;42(Supplement1):25–34.

Article  Google Scholar 

Kankalil George S, Suseela MR, El Safi S, Ali Elnagi E, Al-Naam YA, Adlan Mohammed Adam A, et al. Molecular determination of van genes among clinical isolates of enterococci at a hospital setting. Saudi J Biol Sci. 2021;28(5):2895–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harbarth S, Cosgrove S, Carmeli Y. Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci. Antimicrob Agents Chemother. 2002;46(6):1619–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization., https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 5 April 2023.

WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2022–2020 data. Copenhagen: WHO Regional Office for Europe; 2022.

Google Scholar 

Zhou X, Willems RJL, Friedrich AW, Rossen JWA, Bathoorn E. Enterococcus faecium: from microbiological insights to practical recommendations for Infection control and diagnostics. Antimicrob Resist Infect Control. 2020;9(1):130.

Article  PubMed  PubMed Central  Google Scholar 

Morgan DJ, Pineles L, Shardell M, Graham MM, Mohammadi S, Forrest GN, et al. The Effect of Contact precautions on Healthcare Worker Activity in Acute Care hospitals. Infect Control Hosp Epidemiol. 2013;34(1):69–73.

Article  PubMed  Google Scholar 

Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, et al. Risk-factors and predictors of mortality in patients colonised with Vancomycin-resistant enterococci. Clin Microbiol Infect. 2008;14(1):14–21.

Article  CAS  PubMed  Google Scholar 

López-Luis BA, Sifuentes-Osornio J, Lambraño-Castillo D, Ortiz-Brizuela E, Ramírez-Fontes A, Tovar-Calderón YE, et al. Risk factors and outcomes associated with Vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: a 10-year study in a tertiary-care centre in Mexico City. J Glob Antimicrob Resist. 2021;24:198–204.

Article  PubMed  Google Scholar 

Billington EO, Phang SH, Gregson DB, Pitout JDD, Ross T, Church DL, et al. Incidence, risk factors, and outcomes for Enterococcus spp. Blood Stream Infections: a Population-based study. Int J Infect Dis. 2014;26:76–82.

Article  CAS  PubMed  Google Scholar 

Kampmeier S, Kossow A, Clausen LM, Knaack D, Ertmer C, Gottschalk A, et al. Hospital acquired Vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study. Antimicrob Resist Infect Control. 2018;7(1):103.

Article  PubMed  PubMed Central  Google Scholar 

Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, et al. VRE and VSE Bacteremia Outcomes in the era of effective VRE therapy: a systematic review and Meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):26–35.

Article  PubMed  Google Scholar 

Dubler S, Lenz M, Zimmermann S, Richter DC, Weiss KH, Mehrabi A, et al. Does Vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study. Antimicrob Resist Infect Control. 2020;9(1):22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, et al. The importance of adjusting for enterococcus species when assessing the burden of Vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream Infections. Antimicrob Resist Infect Control. 2018;7(1):133.

Article  PubMed  PubMed Central  Google Scholar 

Hayden MK. Insights into the Epidemiology and Control of Infection with Vancomycin-Resistant Enterococci. Clin Infect Dis. 2000;31(4):1058–65.

Article  CAS  PubMed  Google Scholar 

Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream Infection among patients with malignancy: a systematic review and Meta-analysis. Open Forum Infect Dis. 2017;4(1).

Ford CD, Lopansri BK, Haydoura S, Snow G, Dascomb KK, Asch J, et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and Infection in patients with newly diagnosed Acute Leukemia: different patterns in patients with Acute Myelogenous and Acute Lymphoblastic Leukemia. Infect Control Hosp Epidemiol. 2015;36(1):47–53.

Article  PubMed  Google Scholar 

Worth LJ, Thursky KA, Seymour JF, Slavin MA. Vancomycin-resistant Enterococcus faecium Infection in patients with hematologic malignancy: patients with acute Myeloid Leukemia are at high-risk. Eur J Haematol. 2007;79(3):226–33.

Article  PubMed  Google Scholar 

Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, et al. Colonization, Bloodstream Infection, and Mortality caused by vancomycin-resistant Enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2007;13(5):615–21.

Article  PubMed  Google Scholar 

Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E. MRSA and VRE colonization in solid organ transplantation: a Meta-analysis of published studies. Am J Transplant. 2014;14(8):1887–94.

Article  CAS  PubMed  Google Scholar 

Ford CD, Gazdik MA, Lopansri BK, Webb B, Mitchell B, Coombs J, et al. Vancomycin-resistant Enterococcus colonization and bacteremia and hematopoietic stem cell transplantation outcomes. Biol Blood Marrow Transplant. 2017;23(2):340–6.

Article  PubMed  Google Scholar 

Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated Infections. Curr Opin Infect Dis. 2013;26(4):338–44.

Article  PubMed  Google Scholar 

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E et al. Evaluation of risk factors for Vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Transpl Infect Disease. 2013;n/a-n/a

Rosko AE, Corriveau M, Suwantarat N, Arfons L, Treasure M, Parker P, et al. Vancomycin-resistant enterococci Infection: not just for the transplanted. Leuk Lymphoma. 2014;55(6):1320–5.

Article  CAS  PubMed  Google Scholar 

Kirkizlar TA, Akalin H, Kirkizlar O, Ozkalemkas F, Ozkocaman V, Kazak E, et al. Vancomycin-resistant enterococci Infection and predisposing factors for Infection and mortality in patients with acute Leukaemia and febrile neutropenia. Leuk Res. 2020;99:106463.

Article  CAS  PubMed  Google Scholar 

Papanicolaou GA, Ustun C, Young JAH, Chen M, Kim S, Woo Ahn K, et al. Bloodstream Infection due to Vancomycin-resistant Enterococcus is Associated with increased mortality after hematopoietic cell transplantation for Acute Leukemia and Myelodysplastic Syndrome: a Multicenter, Retrospective Cohort Study. Clin Infect Dis. 2019;69(10):1771–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamboj M, Cohen N, Huang YT, Kerpelev M, Jakubowski A, Sepkowitz KA, et al. Impact of empiric treatment for vancomycin-resistant Enterococcus in colonized patients early after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019;25(3):594–8.

Article  CAS  PubMed  Google Scholar 

Webb BJ, Healy R, Majers J, Burr Z, Gazdik M, Lopansri B, et al. Prediction of bloodstream Infection due to vancomycin-resistant Enterococcus in patients undergoing Leukemia induction or hematopoietic stem-cell transplantation. Clin Infect Dis. 2017;64(12):1753–9.

Article  CAS  PubMed  Google Scholar 

Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.

Article  CAS  PubMed  Google Scholar 

Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, et al. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic disorders. J Neurogastroenterol Motil. 2021;27(1):19–34.

Article  PubMed  PubMed Central  Google Scholar 

D’Angelo G. Microbiota and Hematological Diseases. Int J Hematol Oncol Stem Cell Res. 2022.

Stevens VW, Khader K, Echevarria K, Nelson RE, Zhang Y, Jones M, et al. Use of oral vancomycin for Clostridioides difficile Infection and the risk of vancomycin-resistant Enterococci. Clin Infect Dis. 2020;71(3):645–51.

Article  CAS  PubMed  Google Scholar 

Ling R, Achonu C, Li Y, Katz KC, Garber G, Johnstone J. Investigating the relationship between Vancomycin-resistant Enterococcus control practices and the incidence of health care–associated Clostridioides difficile Infections in Ontario. Am J Infect Control. 2020;48(3):324–6.

Article  PubMed  Google Scholar 

Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Aydın D, Demirel N, et al. Which multidrug-resitant Bacteria are emerging in patients with hematological malignancies? One-year report. Indian J Hematol Blood Transfus. 2015;31(1):51–6.

Article  PubMed  Google Scholar 

DiazGranados CA, Jernigan JA. Impact of Vancomycin Resistance on Mortality among patients with Neutropenia and Enterococcal Bloodstream Infection. J Infect Dis. 2005;191(4):588–95.

Article  CAS  PubMed  Google Scholar 

White L, Ybarra M. Neutropenic Fever. Hematol Oncol Clin North Am. 2017;31(6):981–93.

Article  PubMed